IDF2022-0796 Sustained weight loss with ertugliflozin in patients with T2D and atherosclerotic cardiovascular disease in VERTIS CV
| Autor: | Cosentino, F., Dagogo-Jack, S., Frederich, R., Cannon, C.P., Cherney, D.Z.I., Mancuso, J.P., Wynant, W., Liu, J., Cater, N.B., Pratley, R.E. |
|---|---|
| Zdroj: | In Diabetes Research and Clinical Practice March 2023 197 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect